Skip Navigation



Japanese Journal of Clinical Oncology Advance Access published online on January 25, 2006
Japanese Journal of Clinical Oncology, doi:10.1093/jjco/hyi219
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
36/1/60    most recent
hyi219v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Takaoka, E.-I.
Right arrow Articles by Akaza, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takaoka, E.-I.
Right arrow Articles by Akaza, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 Foundation for Promotion of Cancer Research
Received July 31, 2005
Accepted November 7, 2005

Case Report

Neutropenic Colitis during Standard Dose Combination Chemotherapy with Nedaplatin and Irinotecan for Testicular Cancer

Ei-Ichiro Takaoka 1 *, Koji Kawai 1, Satoshi Ando 1, Toru Shimazui 1, and Hideyuki Akaza 1

1 Department of Urology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan

* To whom correspondence should be addressed.
Ei-Ichiro Takaoka, E-mail: tach-tech-voice{at}mvb.biglobe.ne.jp


  Abstract

A 54-year-old man received combination chemotherapy with nedaplatin and irinotecan as salvage chemotherapy for refractory non-seminomatous testicular cancer. The patient developed abdominal pain and high fever on Day 21 after the initiation of chemotherapy. Computed tomography revealed thickening of the terminal ileum wall and paralytic ileus. The patient recovered with intensive supportive management including broad-spectrum antibiotics, bowel rest with gastric intubation and intravenous {gamma}-globulin. Neutropenic colitis has been thought to be a serious gastrointestinal complication associated with chemotherapy for hematological malignancy. The mortality rate is as high as 21-48% according to a recent review. The present case indicates that the neutropenic colitis can occur under neutropenic conditions induced by the standard-dose chemotherapy for solid cancer.

Keywords: solid cancer; chemotherapy; neutropenic colitis text.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.